Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.

Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.

Item
http://www.wikidata.org/entity/Q43993972
Anti-PEG immunity: emergence, characteristics, and unaddressed questions.PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryUnderstanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissueAccelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationAssessing the effect of a nude mouse model on nanoparticle-mediated gene delivery.Effect of charge ratio on lipoplex-mediated gene delivery and liver toxicity.Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics.Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production.Cleavable PEGylation: a strategy for overcoming the "PEG dilemma" in efficient drug delivery.Biodistribution and toxicity of orally administered poly (lactic-co-glycolic) acid nanoparticles to F344 rats for 21 days.pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin.Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.
P2860

Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.

Item
http://www.wikidata.org/entity/Q43993972
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
type
label
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
prefLabel
Accelerated blood clearance of ...... encapsulated anticancer drug.
@en
Accelerated blood clearance of ...... encapsulated anticancer drug.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Accelerated blood clearance of ...... d encapsulated anticancer drug
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921